124 related articles for article (PubMed ID: 12190310)
1. Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography.
Wright SW; Carlo AA; Carty MD; Danley DE; Hageman DL; Karam GA; Levy CB; Mansour MN; Mathiowetz AM; McClure LD; Nestor NB; McPherson RK; Pandit J; Pustilnik LR; Schulte GK; Soeller WC; Treadway JL; Wang IK; Bauer PH
J Med Chem; 2002 Aug; 45(18):3865-77. PubMed ID: 12190310
[TBL] [Abstract][Full Text] [Related]
2. Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines.
Wright SW; Hageman DL; McClure LD; Carlo AA; Treadway JL; Mathiowetz AM; Withka JM; Bauer PH
Bioorg Med Chem Lett; 2001 Jan; 11(1):17-21. PubMed ID: 11140724
[TBL] [Abstract][Full Text] [Related]
3. 3-(2-carboxyethyl)-4,6-dichloro-1H-indole-2-carboxylic acid: an allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site.
Wright SW; Carlo AA; Danley DE; Hageman DL; Karam GA; Mansour MN; McClure LD; Pandit J; Schulte GK; Treadway JL; Wang IK; Bauer PH
Bioorg Med Chem Lett; 2003 Jun; 13(12):2055-8. PubMed ID: 12781194
[TBL] [Abstract][Full Text] [Related]
4. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors.
Wissner A; Berger DM; Boschelli DH; Floyd MB; Greenberger LM; Gruber BC; Johnson BD; Mamuya N; Nilakantan R; Reich MF; Shen R; Tsou HR; Upeslacis E; Wang YF; Wu B; Ye F; Zhang N
J Med Chem; 2000 Aug; 43(17):3244-56. PubMed ID: 10966743
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Li Z; Mu Y; Xu B; Shen Z
Eur J Med Chem; 2015 Jan; 90():394-405. PubMed ID: 25461330
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
Assefa H; Kamath S; Buolamwini JK
J Comput Aided Mol Des; 2003 Aug; 17(8):475-93. PubMed ID: 14703120
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors.
Rosini M; Mancini F; Tarozzi A; Colizzi F; Andrisano V; Bolognesi ML; Hrelia P; Melchiorre C
Bioorg Med Chem; 2006 Dec; 14(23):7846-53. PubMed ID: 16908175
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors.
Lü S; Zheng W; Ji L; Luo Q; Hao X; Li X; Wang F
Eur J Med Chem; 2013 Mar; 61():84-94. PubMed ID: 22867529
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
Dang Q; Kasibhatla SR; Reddy KR; Jiang T; Reddy MR; Potter SC; Fujitaki JM; van Poelje PD; Huang J; Lipscomb WN; Erion MD
J Am Chem Soc; 2007 Dec; 129(50):15491-502. PubMed ID: 18041834
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.
Han X; Huang Y; Wei L; Chen H; Guo Y; Tang Z; Hu W; Xia Q; Wang Q; Yan J; Ren Y
Bioorg Med Chem; 2020 Sep; 28(18):115624. PubMed ID: 32828433
[TBL] [Abstract][Full Text] [Related]
13. Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode.
von Geldern TW; Lai C; Gum RJ; Daly M; Sun C; Fry EH; Abad-Zapatero C
Bioorg Med Chem Lett; 2006 Apr; 16(7):1811-5. PubMed ID: 16442285
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the active site mutant (Arg-243-->Ala) in the T and R allosteric states of pig kidney fructose-1,6-bisphosphatase expressed in Escherichia coli.
Stec B; Abraham R; Giroux E; Kantrowitz ER
Protein Sci; 1996 Aug; 5(8):1541-53. PubMed ID: 8844845
[TBL] [Abstract][Full Text] [Related]
15. Fructose-1,6-bisphosphatase: arginine-22 is involved in stabilization of the T allosteric state.
Lu G; Williams MK; Giroux EL; Kantrowitz ER
Biochemistry; 1995 Oct; 34(41):13272-7. PubMed ID: 7577911
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
Liao BR; He HB; Yang LL; Gao LX; Chang L; Tang J; Li JY; Li J; Yang F
Eur J Med Chem; 2014 Aug; 83():15-25. PubMed ID: 24946215
[TBL] [Abstract][Full Text] [Related]
17. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
Erion MD; Dang Q; Reddy MR; Kasibhatla SR; Huang J; Lipscomb WN; van Poelje PD
J Am Chem Soc; 2007 Dec; 129(50):15480-90. PubMed ID: 18041833
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bie J; Liu S; Zhou J; Xu B; Shen Z
Bioorg Med Chem; 2014 Mar; 22(6):1850-62. PubMed ID: 24530031
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the allosteric binding pocket of human liver fructose-1,6-bisphosphatase by protein crystallography and inhibitor activity studies.
Iversen LF; Brzozowski M; Hastrup S; Hubbard R; Kastrup JS; Larsen IK; Naerum L; Nørskov-Lauridsen L; Rasmussen PB; Thim L; Wiberg FC; Lundgren K
Protein Sci; 1997 May; 6(5):971-82. PubMed ID: 9144768
[TBL] [Abstract][Full Text] [Related]
20. Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
Hebeisen P; Haap W; Kuhn B; Mohr P; Wessel HP; Zutter U; Kirchner S; Ruf A; Benz J; Joseph C; Alvarez-Sánchez R; Gubler M; Schott B; Benardeau A; Tozzo E; Kitas E
Bioorg Med Chem Lett; 2011 Jun; 21(11):3237-42. PubMed ID: 21550236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
